Ngôn ngữ sử dụng
Cách trích dẫn
Tải xuống
Tóm tắt
Objective: To evaluate the clinical characteristics and quality of life (QoL) of atrial fibrillation (AF) patients before and after radiofrequency catheter ablation, using the Atrial Fibrillation Effect on Quality of Life (AFEQT) questionnaire.
Methods: A longitudinal follow-up study was conducted on 57 patients who underwent radiofrequency catheter ablation at the Department of Cardiology, Military Hospital 103, from March 2023 to June 2025. Clinical characteristics were obtained through medical interviews and record reviews. QoL was assessed using the AFEQT questionnaire at baseline and at 3 months post-ablation.
Results: The mean age of the study population was 61.8 ± 10.9 years, with a male-to-female ratio of 2.8:1. The prevalence of hypertension, type 2 diabetes mellitus, chronic coronary syndrome, and heart failure was 57.9%, 14.0%, 7.0%, and 12.3%, respectively. Most patients had paroxysmal atrial fibrillation (70.1%) and a time from AF diagnosis to ablation of ≤ 1 year (64.7%). Common symptoms included palpitations, dizziness/lightheadedness, and chest discomfort. At the 3-month follow-up, both clinical symptoms and AFEQT scores (overall and across all subscales) improved significantly (p < 0.05). Improvements were particularly notable in male patients, those aged ≥ 60 years, those without heart failure, those with paroxysmal atrial fibrillation, and those adherent to treatment (p < 0.05).
Conclusion: Radiofrequency catheter ablation significantly improved clinical symptoms and QoL at 3 months post-procedure, especially among male, older adult patients with paroxysmal AF, no heart failure, and good treatment adherence.
Từ khóa
Tài liệu tham khảo
Elliott AD, Middeldorp ME, Van Gelder IC, Albert CM, Sanders P. Author Correction: Epidemiology and modifiable risk factors for atrial fibrillation.Nat Rev Cardiol. Jun 2023;20(6):429. doi:10.1038/s41569-023-00834-w
Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.Circulation. Aug 31 2004;110(9):1042-6. doi:10.1161/01.CIR.0000140263.20897.42
January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.J Am Coll Cardiol. Dec 2 2014;64(21):e1-76. doi:10.1016/j.jacc.2014.03.022
Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.Am J Med. Oct 1 2002;113(5):359-64. doi:10.1016/s0002-9343(02)01236-6
Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.JAMA. Jan 27 2010;303(4):333-40. doi:10.1001/jama.2009.2029
Wolfes J, Eckardt L. [The 2024 ESC guidelines for management of atrial fibrillation : AF-CARE as new credo].Herzschrittmacherther Elektrophysiol. Dec 2024;35(4):318-323. Die 2024 ESC-Leitlinien zum Management von Vorhofflimmern : AF-CARE als neues Credo. doi:10.1007/s00399-024-01053-7
Arbelo E, Brugada J, Blomstrom-Lundqvist C, et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry.Euro Heart J. May 1 2017;38(17):1303-1316. doi:10.1093/eurheartj/ehw564
Kotalczyk A, Lip GY, Calkins H. The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation.Arrhythm Electrophysiol Rev. Jul 2021;10(2):65-67. doi:10.15420/aer.2021.07
Spertus J, Dorian P, Bubien R, et al. Development and validation of the Atrial Fibrillation Effect on Quality-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation.Circ Arrhythm Electrophysiol. Feb 2011;4(1):15-25. doi:10.1161/CIRCEP.110.958033
Skála T. Follow-up of patients after catheter ablation of atrial fibrillation and their clinical management.Cor and Vasa. 2012;54(6):428-432.
Chew DS, Black-Maier E, Loring Z, et al. Diagnosis-to-Ablation Time and Recurrence of Atrial Fibrillation Following Catheter Ablation: A Systematic Review and Meta-Analysis of Observational Studies.Circ Arrhythm Electrophysiol. Apr 2020;13(4):e008128. doi:10.1161/CIRCEP.119.008128
Kistler PM, Chieng D. Persistent atrial fibrillation in the setting of pulmonary vein isolation-Where to next?J Cardiovasc Electrophysiol. Jul 2020;31(7):1857-1860. doi:10.1111/jce.14298
Paul Nordin A, Drca N, Insulander P, et al. Low incidence of major complications after the first six hours post atrial fibrillation ablation: Is same-day discharge safe and feasible in most patients?J Cardiovasc Electrophysiol. Nov 2021;32(11):2953-2960. doi:10.1111/jce.15243
Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigative therapy.J Am Coll Cardiol. Oct 2000;36(4):1303-9. doi:10.1016/s0735-1097(00)00886-x
Zulmiyusrini P, Yamin M, Muhadi M, Kurniawan J, Salim S. The validity and reliability of Indonesian version of atrial fibrillation effect on quality of life (AFEQT) questionnaire for atrial fibrillation patients.J Patient Rep Outcomes. Dec 15 2023;7(1):133. doi:10.1186/s41687-023-00672-x
Hsieh MH, Chiou CW, Wen ZC, et al. Alterations of heart rate variability after radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins.Circulation. Nov 30 1999;100(22):2237-43. doi:10.1161/01.cir.100.22.2237
Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.JAMA. Apr 2 2019;321(13):1261-1274. doi:10.1001/jama.2019.0693
Nguyen Lan Viet PMH. Evaluation of the effectiveness and safety of radiofrequency ablation of atrial fibrillation at the Vietnam Heart Institute.Vietnam Journal of Cardiology. 2021;95(25):25-32.
Weerasooriya R, Khairy P, Litalien J, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?J Am Coll Cardiol. Jan 11 2011;57(2):160-6. doi:10.1016/j.jacc.2010.05.061
Fitzgerald JL, Middeldorp ME, Gallagher C, Sanders P. Lifestyle Modification and Atrial Fibrillation: Critical Care for Successful Ablation.J Clin Med. May 9 2022;11(9)doi:10.3390/jcm11092660
Kircher S, Hindricks G, Sommer P. Long-term success and follow-up after atrial fibrillation ablation.Curr Cardiol Rev. Nov 2012;8(4):354-61. doi:10.2174/157340312803760758.
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại 4.0 International Giấy phép .
Bản quyền (c) 2025 Tạp chí Khoa học Điều dưỡng